Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-045527·EcoR1 Capital, LLC
Schedule 13D ownership disclosure
LAKEFRONT BIOTHERAPEUTICS NV
Ordinary Shares, no par value · CUSIP: 36315X101
Event date: 2025-05-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- EcoR1 Capital, LLCReported CIK 0001587114
Shares: 7,803,202.00 · Class: 11.84%
- Oleg NodelmanReported CIK 0001454385
Shares: 7,803,202.00 · Class: 11.84%
- EcoR1 Capital Fund Qualified, L.P.Reported CIK 0001598292
Shares: 7,339,498.00 · Class: 11.14%
- EcoR1 Capital Fund, L.P.Reported CIK 0001567938
Shares: 463,704.00 · Class: 0.70%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-045527
- Form type
- SCHEDULE 13D/A
- Filer
- EcoR1 Capital, LLC
- CIK
- CIK 1587114
- Filed
- May 19, 2025
- Reporting period
- May 15, 2025
- Description
- Schedule 13D beneficial ownership